OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
October 20, 2005
Patheon, CEPH Begin Corrective Action Program for Omnicef OP
October 02, 2005
Growth is critical to a strong company, and not only because it generates economies of scale.
September 20, 2005
A CMO in Singapore manufacturing commercial biopharmaceuticals is the result of a partnership between two biopharmaceutical companies.
September 02, 2005
A summertime burst of acquisition activity in CMC development services prompts the question: a coincidence of timing or the start of a trend?
September 01, 2005
Contract manufacturers serving the biopharmaceutical market add capacity in a bet on renewed growth for biomanufacturing.
August 02, 2005
The pharmaceutical outsourcing industry is well into its second year of very strong growth, and indications appear that it will enjoy a healthy third year as well.
August 01, 2005
Cold chain management is becoming pivotal to success in the pharmaceutical industry.
By forming strategic collaborative partnerships with contract research organizations, pharmaceutical companies can take advantage of several strategies for accelerating drug development, maximizing profitability, and extending patent exclusivity.
New maintenance models focused on efficiency improvements can deliver cost savings and enhanced service quality.
2005 has been a good year for the contract services industry, and 2006 promises to be nearly as successful, according to the 2005 PharmSource–Pharmaceutical Technology outsourcing survey. But as pharmaceutical outsourcing activity grows, companies are looking for more sophisticated ways to manage and control their contract services expenditures.